Search

Mimosa De

Examiner (ID: 17726)

Most Active Art Unit
2913
Art Unit(s)
2913, 5332, 2900, 2931
Total Applications
6546
Issued Applications
6484
Pending Applications
21
Abandoned Applications
45

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17859822 [patent_doc_number] => 11440968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-13 [patent_title] => Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) [patent_app_type] => utility [patent_app_number] => 16/317972 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8680 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317972 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/317972
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) Jul 16, 2017 Issued
Array ( [id] => 17281713 [patent_doc_number] => 11198734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => Anti-Axl antagonistic antibodies [patent_app_type] => utility [patent_app_number] => 16/098933 [patent_app_country] => US [patent_app_date] => 2017-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 35388 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098933 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098933
Anti-Axl antagonistic antibodies Jun 20, 2017 Issued
Array ( [id] => 15035793 [patent_doc_number] => 20190328901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS [patent_app_type] => utility [patent_app_number] => 16/310738 [patent_app_country] => US [patent_app_date] => 2017-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36630 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -134 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310738 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/310738
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS Jun 18, 2017 Abandoned
Array ( [id] => 15035705 [patent_doc_number] => 20190328857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => CALR AND JAK2 VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/308164 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308164 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308164
CALR AND JAK2 VACCINE COMPOSITIONS Jun 8, 2017 Abandoned
Array ( [id] => 15342471 [patent_doc_number] => 20200009127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => USE OF MTOR INHIBITOR AND CHLOROQUINE FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/490892 [patent_app_country] => US [patent_app_date] => 2017-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3629 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/490892
Use of mTOR inhibitor and chloroquine for treating cancer Mar 7, 2017 Issued
Array ( [id] => 16326900 [patent_doc_number] => 20200297865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO [patent_app_type] => utility [patent_app_number] => 15/779446 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779446 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/779446
Conjugates comprising self-immolative groups and methods related thereto Nov 22, 2016 Issued
Array ( [id] => 19472626 [patent_doc_number] => 12102689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Anti-CD22 antibody-maytansine conjugates and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/774384 [patent_app_country] => US [patent_app_date] => 2016-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 31 [patent_no_of_words] => 46673 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774384 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/774384
Anti-CD22 antibody-maytansine conjugates and methods of use thereof Nov 7, 2016 Issued
Array ( [id] => 9518956 [patent_doc_number] => 20140155448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'AMINO-ACID-CONTAINING COMPOSITION FOR ENHANCING RECOVERY FROM MUSCLE FATIGUE' [patent_app_type] => utility [patent_app_number] => 14/175154 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4712 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175154 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/175154
Amino-acid-containing composition for enhancing recovery from muscle fatigue Feb 6, 2014 Issued
Menu